Need professional-grade analysis? Visit stockanalysis.com
$58.05M
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Instil Bio Inc. (TIL) Price Performance
Instil Bio Inc. (TIL) trades on United States in USD. The company is classified in the Healthcare sector under the Biological Products industry. The stock currently trades at $8.56, up 0.12% from the previous close.
Over the past year, TIL has traded between a low of $6.66 and a high of $37.56. The stock has lost 52.4% over this period. It is currently 77.2% below its 52-week high.
Instil Bio Inc. has a market capitalization of $58.05M.
About Instil Bio Inc.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial for the treatment of patients with chemotherapy in patients with advanced/metastatic non-small cell lung cancer. The company also conducts a Phase 1 open label trial in China for AXN-2510/IMM2510 as monotherapy in patients with advanced solid tumors, including triple-negative breast cancer, squamous non-small cell lung cancer, hepatocellular carcinoma, renal cell carcinoma, and rare solid tumors, such as soft tissue sarcomas and thymic cancer. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Company Info
- Sector
- Healthcare
- Industry
- Biological Products
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- N/A
- EBITDA
- $-56,521,000
- Profit Margin
- N/A
- EPS (TTM)
- -11.71
- Book Value
- 17.76
Technical Indicators
- 52 Week High
- $42.79
- 52 Week Low
- $5.67
- 50 Day MA
- $8.09
- 200 Day MA
- $18.27
- Beta
- 2.05
Valuation
- Trailing P/E
- N/A
- Forward P/E
- -0.58
- Price/Sales
- N/A
- Price/Book
- 0.48
- Enterprise Value
- $63.30M